Women s and Men s Health Infections and Hematologic Systems Part I CASE STUDY HH is a 68 yo M who has been

Women’s and Men’s Health/Infections and Hematologic Systems, Part I

CASE STUDY

HH is a 68 yo M who has been admitted to the medical ward with community-acquired pneumonia for the past 3 days. His PMH is significant for COPD, HTN, hyperlipidemia, and diabetes. He remains on empiric antibiotics, which include ceftriaxone 1 g IV qday (day 3) and azithromycin 500 mg IV qday (day 3). Since admission, his clinical status has improved, with decreased oxygen requirements. He is not tolerating a diet at this time with complaints of nausea and vomiting.      Ht: 5’8”    Wt: 89 kg      Allergies: Penicillin (rash)

Required Reading.

Rosenthal, L. D., & Burchum, J. R. (2021). Lehne’s pharmacotherapeutics for advanced practice nurses and physician assistants (2nd ed.) St. Louis, MO: Elsevier.

· Chapter 46, “Anticoagulant and Antiplatelet Drugs” (pp. 364–371)

· Chapter 47, “Drugs for Deficiency Anemias” (pp. 389–396)

· Chapter 50, “Estrogens and Progestins: Basic Pharmacology and Noncontraceptive Applications” (pp. 425–436)

· Chapter 51, “Birth Control” (pp. 437–446)

· Chapter 52, “Androgens” (pp. 447–453)

· Chapter 53, “Male Sexual Dysfunction and Benign Prostatic Hyperplasia” (pp. 454–466)

· Chapter 70, “Basic Principles of Antimicrobial Therapy” (pp. 651–661)

· Chapter 71, “Drugs That Weaken the Bacterial Cell Wall I: Penicillins” (pp. 662–668)

· Chapter 75, “Sulfonamides Antibiotics and Trimethoprim” (pp. 688–694)

· Chapter 76, “Drug Therapy of Urinary Tract Infections” (pp. 695–699)

· Chapter 78, “Miscellaneous Antibacterial Drugs” (pp. 711–714)

· Chapter 79, “Antifungal Agents” (pp. 715–722)

· Chapter 80, “Antiviral Agents I: Drugs for Non-HIV Viral Infections” (pp. 723–743)

· Chapter 82, “Drug Therapy of Sexually Transmitted Diseases” (pp. 763–770)

Discussion: Women’s and Men’s Health, Infectious Disease, and Hematologic Disorders

As an advanced practice nurse, you will likely experience patient encounters with complex comorbidities. For example, consider a female patient who is pregnant who also presents with hypertension, diabetes, and has a recent tuberculosis infection. How might the underlying pathophysiology of these conditions affect the pharmacotherapeutics you might recommend to help address your patient’s health needs? What education strategies might you recommend for ensuring positive patient health outcomes?

For this Discussion, you will be assigned a patient case study and will consider how to address the patient’s current drug therapy plans. You will then suggest recommendations on how to revise these drug therapy plans to ensure effective, safe, and quality patient care for positive patient health outcomes.

Post a brief description of your patient’s health needs from the patient case study you assigned. Be specific. Then, explain the type of treatment regimen you would recommend for treating your patient, including the choice or pharmacotherapeutics you would recommend and explain why. Be sure to justify your response. Explain a patient education strategy you might recommend for assisting your patient with the management of their health needs. Be specific and provide examples.

At least 3 citations using APA 7th edition